Download PDF
1 / Pages

Other users also viewed these articles

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC Federico Piñero; Margarita Anders; Carla Bermudez; Ezequiel Demirdjian; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Norberto Tamagnone; Virginia Reggiardo; Hugo Cheinquer; Alexandre Araujo; Diego Arufe; Juan Ignacio Marín; Natalia Ratusnu; Estela Manero; Daniela Perez; Marina Villa; Federico Orozco; Dolores Murga; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2023;28:
P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Ezequiel Demirdjian; Adriana Varón; Daniela Perez; Jorge Rodriguez; Oscar Beltrán; Javier Delgado García; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Alexandre Araujo; Juan Diego Torres Florez; Juan Ignacio Marín; Marina Villa; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2024;29 Supl 3:
P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Diego Arufe; Adriana Varón; Ana Palazzo; Jorge Rodríguez; Oscar Beltrán; Patricio Palavecino Rubilar; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Norberto Tamagnone; Hugo Cheinquer; Nicolás Cortés Medina; Juan Ignacio Marín; Estela Manero; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Virginia Reggiardo; Manuel Mendizabal;
Ann Hepatol. 2024;29 Supl 3: